A phase I dose escalation trial of vaccine replicon particles (VRP) expressing prostate-specific membrane antigen (PSMA) in patients (pts) with castration-resistant prostate cancer (CRPC): Preliminary results Meeting Abstract


Authors: Slovin, S. F.; Kargman, M.; Durso, R.; Curley, T.; Israel, R. J.; Olson, W. C.; Morris, S.; Murphy, D.; Scher, H. I.
Abstract Title: A phase I dose escalation trial of vaccine replicon particles (VRP) expressing prostate-specific membrane antigen (PSMA) in patients (pts) with castration-resistant prostate cancer (CRPC): Preliminary results
Meeting Title: 2011 Genitourinary Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 29
Issue: 7 Suppl.
Meeting Dates: 2011 Feb 17-19
Meeting Location: Orlando, FL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2011-03-01
Language: English
ACCESSION: WOS:000208880700141
DOI: 10.1200/jco.2011.29.7_suppl.140
PROVIDER: wos
Notes: Meeting Abstract: 140 -- Source: Wos
Altmetric Score
MSK Authors
  1. Susan Slovin
    186 Slovin
  2. Howard Scher
    834 Scher
  3. Diane M Murphy
    2 Murphy